CXD101 in Immunotherapy-related Liver Cancer
Clinical trial NCT05873244 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05873244
- Sponsor
- Stephen Chan Lam
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-21
- Primary completion
- 2027-12-30
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.